Here we have described the evidence-based selection of suitable chemicals for the development and validation of PPARα and PPARγ as molecular-level events, and white adipose tissue adipogenesis as an apical organ/tissue-level adverse effect for obesity. This evidence concerns the gene PPARG and obesity disorder.